| Metric | Oct 23, 2024 FY24 Q3 | Feb 12, 2025 FY24 Q4 | Apr 30, 2025 FY25 Q1 | Jul 23, 2025 FY25 Q2 | Oct 22, 2025 FY25 Q3 | Feb 18, 2026 FY25 Q4 | Apr 29, 2026 FY26 Q1 | Jul 22, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Fee-related and other revenues | — | — | — | — | — | New“$1.46 - $1.49 billion” | — | — |
| Marketing fund revenues versus expenses | — | — | — | — | — | — | — | New“roughly equal” |
| Marketing fund revenues vs. expenses | — | — | — | — | — | New“roughly equal” | Revised“roughly equal expenses” | — |
| Net revenues | — | — | — | — | — | — | — | New“$1.48 - $1.50 billion” |
| Net revenues (Table 8 Outlook) | — | — | — | — | — | — | New“$ 1,465 – 1,495” | — |
| Net revenues (Updated Outlook) | — | — | — | — | — | — | New“$1.47 - $1.50 billion” | — |
| Net revenues from foreclosed Revo properties | — | — | — | — | — | — | New“approximately $10 million” | — |
| Adjusted diluted EPS | — | — | — | — | — | New“$4.62 - $4.80” | — | Raised“$4.71 - $4.83” |
| Adjusted diluted EPS (Updated Outlook) | — | — | — | — | — | — | New“$4.62 - $4.80” | — |
| Adjusted EBITDA | — | — | — | — | — | New“$730 - $745 million” | — | Narrowed“$735 - $745 million” |
| Adjusted EBITDA (a) | — | — | — | — | — | New“730 – 745” | — | Narrowed“735 – 745” |
| Adjusted EBITDA (Table 8 Outlook) | — | — | — | — | — | — | New“730 – 745” | — |
| Adjusted EBITDA (Updated Outlook) | — | — | — | — | — | — | New“$730 - $745 million” | — |
| Adjusted EBITDA comparable basis growth rate | — | — | — | — | — | — | — | New“5% - 7%” |
| Adjusted EBITDA comparable basis growth rate (excluding Revo deferral and one-time cost reductions) | — | — | — | — | — | — | New“5% - 7%” | — |
| Adjusted EBITDA growth rate (comparable basis) | — | — | — | — | — | New“5% - 7%” | — | — |
| Adjusted net income | — | — | — | — | — | New“$354 - $368 million” | — | Narrowed“$355 - $365 million” |
| Adjusted net income (Updated Outlook) | — | — | — | — | — | — | New“$351 - $365 million” | — |
| Adjusted income before income taxes | — | — | — | — | — | New“473 – 492” | — | Narrowed“473 – 487” |
| Adjusted income before income taxes (Table 8 Outlook) | — | — | — | — | — | — | New“468 – 487” | — |
| Amortization of acquisition-related intangible assets (excluded from D&A outlook) | — | — | — | — | — | — | — | New“approximately $25 million” |
| Capital expenditures | — | — | — | — | — | New“$40 – 45” | — | Reiterated“$40 – 45” |
| Capital expenditures (Table 8 Outlook) | — | — | — | — | — | — | New“$40 – 45” | — |
| Depreciation and amortization expense (b) | — | — | — | — | — | New“36 – 38” | — | Reiterated“36 – 38” |
| Depreciation and amortization expense (Table 8 Outlook) | — | — | — | — | — | — | New“36 – 38” | — |
| Development advance notes | — | — | — | — | — | New“Approx. $110” | — | Reiterated“Approx. $110” |
| Development advance notes (Table 8 Outlook) | — | — | — | — | — | — | New“Approx. $110” | — |
| Development advance notes amortization expense | — | — | — | — | — | New“35 – 37” | — | Reiterated“35 – 37” |
| Development advance notes amortization expense (Table 8 Outlook) | — | — | — | — | — | — | New“35 – 37” | — |
| Diluted shares (d) | — | — | — | — | — | New“76.7” | — | Lowered“75.4” |
| Diluted shares (Table 8 Outlook) | — | — | — | — | — | — | New“75.9” | — |
| Effective tax rate | — | — | — | — | — | New“approximately 25%” | — | — |
| Effective tax rate assumption | — | — | — | — | — | — | — | New“approximately 25%” |
| Effective tax rate assumption (Table 8 Outlook) | — | — | — | — | — | — | New“approximately 25%” | — |
| Free cash flow conversion rate | — | — | — | — | — | New“55% - 60%” | — | Reiterated“55% - 60%” |
| Free cash flow conversion rate (Updated Outlook) | — | — | — | — | — | — | New“55% - 60%” | — |
| Global RevPAR (e) | — | — | — | — | — | New“(1.5%) - 0.5%” | Narrowed“(1.0%) – 1.0%” | Raised“0.0% – 1.0%” |
| Income tax expense (c) | — | — | — | — | — | New“119 – 124” | — | Lowered“118 – 122” |
| Income tax expense (Table 8 Outlook) | — | — | — | — | — | — | New“117 – 122” | — |
| Interest expense, net | — | — | — | — | — | New“139 – 141” | — | Raised“144 – 146” |
| Interest expense, net (Table 8 Outlook) | — | — | — | — | — | — | New“144 – 146” | — |
| Number of rooms (f) | — | — | — | — | — | New“4.0% - 4.5%” | Reiterated“4.0% – 4.5%” | Reiterated“4.0% – 4.5%” |
| Number of rooms year-over-year growth (Table 8 Outlook) | — | — | — | — | — | — | New“4.0% – 4.5%” | — |
| Quarterly cash dividend | — | — | — | — | — | New“$0.43 per share” | — | — |
| Second half domestic RevPAR | — | — | — | — | — | — | — | New“approximately 2%” |
| Stock-based compensation expense | — | — | — | — | — | New“41 – 43” | — | Reiterated“41 – 43” |
| Stock-based compensation expense (Table 8 Outlook) | — | — | — | — | — | — | New“41 – 43” | — |
| Year-over-year global RevPAR growth | — | — | — | — | — | New“(1.5%) - 0.5%” | — | — |
| Year-over-year global RevPAR growth (Updated Outlook) | — | — | — | — | — | — | New“(1.0%) - 1.0%” | — |
| Year-over-Year Growth: Global RevPAR | — | — | — | — | — | — | — | New“0.0% – 1.0%” |
| Year-over-Year Growth: Number of rooms | — | — | — | — | — | — | — | New“4.0% – 4.5%” |
| Year-over-year rooms growth | — | — | — | — | — | New“4.0% - 4.5%” | — | — |
| For FY2025 | ||||||||
| Fee-related and other revenues | — | New“$1.49 - $1.51 billion” | Lowered“$1.45 - $1.49 billion” | Reiterated“$1.45 - $1.49 billion” | Lowered“$1.43 - $1.45 billion” | — | — | — |
| Marketing fund expenses in excess of revenues | — | — | — | — | New“approximately $5 million” | — | — | — |
| Marketing fund expenses to exceed revenues | — | — | — | — | New“approximately $5 million” | — | — | — |
| Marketing fund revenues relative to expenses | — | — | New“marketing fund revenues to approximate expenses” | — | — | — | — | — |
| Marketing fund revenues vs. expenses | — | New“continues to expect marketing fund revenues to equal expenses” | — | Revised“marketing fund revenues to approximate expenses” | — | — | — | — |
| Adjusted diluted EPS | — | New“$4.66 - $4.78” | Lowered“$4.57 - $4.74” | Raised“$4.60 - $4.78” | Lowered“$4.48 - $4.62” | — | — | — |
| Adjusted EBITDA | — | New“$745 - $755 million” | Lowered“$730 - $745 million” | Reiterated“$730 - $745 million” | Lowered“$715 - $725 million” | — | — | — |
| Adjusted EBITDA (a) | — | New“745 – 755” | — | — | — | — | — | — |
| Adjusted EBITDA generated in first quarter | — | New“roughly 20% of its adjusted EBITDA in the first quarter” | — | — | — | — | — | — |
| Adjusted net income | — | New“$369 - $379 million” | Lowered“$358 - $372 million” | Reiterated“$358 - $372 million” | Lowered“$347 - $358 million” | — | — | — |
| Adjusted free cash flow conversion rate | — | — | — | New“~57%” | Reiterated“~57%” | — | — | — |
| Adjusted income before income taxes | — | New“492 – 506” | Lowered“477 – 496” | Reiterated“477 – 496” | Lowered“463 – 477” | — | — | — |
| Capital expenditures | — | New“$40 – 45” | Reiterated“$40 – 45” | Reiterated“$40 – 45” | Reiterated“$40 – 45” | — | — | — |
| Depreciation and amortization expense (a) | — | — | New“37 – 39” | Reiterated“37 – 39” | Lowered“35 – 37” | — | — | — |
| Depreciation and amortization expense (b) | — | New“39 – 41” | — | — | — | — | — | — |
| Development advance notes | — | New“Approx. $110” | Reiterated“Approx. $110” | Reiterated“Approx. $110” | Reiterated“Approx. $110” | — | — | — |
| Development advance notes amortization expense | — | New“32 – 34” | Reiterated“32 – 34” | Reiterated“32 – 34” | Lowered“31 – 33” | — | — | — |
| Diluted shares (c) | — | — | New“78.4” | Lowered“77.8” | Lowered“77.5” | — | — | — |
| Diluted shares (d) | — | New“79.2” | — | — | — | — | — | — |
| Effective tax rate assumption | — | New“approximately 25%” | Reiterated“approximately 25%” | Reiterated“approximately 25%” | Reiterated“approximately 25%” | — | — | — |
| Free cash flow conversion rate | — | New“57% - 60%” | Lowered“~57%” | — | — | — | — | — |
| Global RevPAR (d) | — | — | New“(2%) – 1%” | — | Lowered“(3%) – (2%)” | — | — | — |
| Global RevPAR (e) | — | New“2% – 3%” | — | — | — | — | — | — |
| Global RevPAR (Year-over-Year Growth, constant currency) | — | — | — | — | New“(3%) – (2%)” | — | — | — |
| Global RevPAR growth, reported basis | — | — | — | — | New“(4%) - (3%)” | — | — | — |
| Income tax expense (b) | — | — | New“119 – 125” | Reiterated“119 – 125” | Lowered“116 – 119” | — | — | — |
| Income tax expense (c) | — | New“123 – 127” | — | — | — | — | — | — |
| Interest expense, net | — | New“134 – 136” | Raised“136 – 138” | Reiterated“136 – 138” | Raised“138 – 140” | — | — | — |
| Marketing fund overspend per RevPAR point | — | — | — | — | New“roughly $2 million” | — | — | — |
| Net room growth outlook | — | — | New“3.6% to 4.6%” | — | — | — | — | — |
| Number of rooms | — | New“3.6% – 4.6%” | — | — | — | — | — | — |
| Number of rooms (Year-over-Year Growth) | — | — | — | — | New“4.0% – 4.6%” | — | — | — |
| Number of rooms growth | — | — | — | New“4.0% – 4.6%” | — | — | — | — |
| Quarterly cash dividend increase | — | New“$0.41 per share” | — | — | — | — | — | — |
| Stock-based compensation expense | — | New“42 – 44” | Reiterated“42 – 44” | Reiterated“42 – 44” | Reiterated“42 – 44” | — | — | — |
| Year-over-year global RevPAR growth | — | — | — | New“(2%) - 1%” | — | — | — | — |
| Year-over-year global RevPAR growth (constant currency) | — | New“2% - 3%” | — | — | — | — | — | — |
| Year-over-year global RevPAR growth (reported basis) | — | New“0.5% - 1.5%” | — | — | — | — | — | — |
| Year-over-Year Growth - Global RevPAR (constant currency) | — | — | New“(2%) – 1%” | — | — | — | — | — |
| Year-over-Year Growth - Global RevPAR (reported basis) | — | — | New“(3%) - 0%” | — | — | — | — | — |
| Year-over-Year Growth - Number of rooms | — | — | New“3.6% – 4.6%” | — | — | — | — | — |
| Year-over-year rooms growth | — | New“3.6% - 4.6%” | — | Narrowed“4.0% - 4.6%” | — | — | — | — |
| For FY2024 | ||||||||
| Fee-related and other revenues | New“$1.41 - $1.43 billion” | — | — | — | — | — | — | — |
| Marketing fund revenues vs. expenses | New“roughly equal” | — | — | — | — | — | — | — |
| Adjusted diluted EPS | New“$4.22 - $4.34” | — | — | — | — | — | — | — |
| Adjusted EBITDA | New“$690 - $700 million” | — | — | — | — | — | — | — |
| Adjusted net income | New“$338 - $348 million” | — | — | — | — | — | — | — |
| Adjusted free cash flow conversion rate | New“~60%” | — | — | — | — | — | — | — |
| Adjusted income before income taxes | New“450 – 464” | — | — | — | — | — | — | — |
| Capital expenditures | New“Approx. $40” | — | — | — | — | — | — | — |
| Depreciation and amortization expense (b) | New“45 – 47” | — | — | — | — | — | — | — |
| Development advance notes | New“Approx. $110” | — | — | — | — | — | — | — |
| Development advance notes amortization expense | New“23 – 25” | — | — | — | — | — | — | — |
| Diluted shares (d) | New“80.1” | — | — | — | — | — | — | — |
| Effective tax rate assumption | New“approximately 25%” | — | — | — | — | — | — | — |
| Global RevPAR | New“Approx. flat” | — | — | — | — | — | — | — |
| Income tax expense (c) | New“113 – 116” | — | — | — | — | — | — | — |
| Interest expense, net | New“125 – 127” | — | — | — | — | — | — | — |
| Net room growth outlook | New“3 to 4%” | — | — | — | — | — | — | — |
| Number of rooms | New“3% – 4%” | — | — | — | — | — | — | — |
| Stock-based compensation expense | New“41 – 43” | — | — | — | — | — | — | — |
| Year-over-year global RevPAR growth | New“Approx. flat” | — | — | — | — | — | — | — |
| Year-over-year rooms growth | New“3 - 4%” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Net debt leverage ratio stated target range | — | — | New“3 to 4 times” | — | — | — | — | Reiterated“3-to-4 times” |
| Net debt leverage ratio stated target range | — | — | — | — | New“3 to 4 times” | — | — | — |
| Net debt leverage ratio target range | — | — | — | New“3 to 4 times” | — | Reiterated“3 to 4 times” | — | — |
| Net debt leverage ratio target range | — | New“3 to 4 times” | — | — | — | — | — | — |